NSE · LYKALABS
Lyka Labs Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,204
of 5,096 stocks
▲ 51W
Peak #2,189 · 27 Sep 2026
Lyka Labs Limited, a microcap Healthcare business, has a subdued return on equity, is seeing revenue slip, and has promoters holding 58%.
Market Cap
304.19 Cr
P/E Ratio
—
P/B Ratio
3.31
ROE
-11.49%
ROCE
-7.00%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 42.31 Cr | 28.03 Cr | 30.73 Cr | 36.66 Cr |
| Net Profit | 2.05 Cr | -8.07 Cr | -15.12 L | -3.21 Cr |
| EPS | 0.57 | -2.13 | 0.00 | -0.94 |
| Operating Profit | 2.96 Cr | -7.88 Cr | 65.63 L | -3.60 Cr |
Shareholding pattern
Promoter
58.45%
Public
41.55%
Mutual fund holdings
₹3.76
Cr total
1
Schemes
1
Fund Houses
₹3.76 Cr
Total Exposure
Quant Mutual Fund₹3.76 Cr (100.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 01 Aug 2024 | Other | Annual General Meeting |
| 21 Jul 2023 | Other | Annual General Meeting |
| 21 Jul 2022 | Other | Annual General Meeting |
| 22 Jul 2021 | Other | Annual General Meeting |
| 16 Sep 2020 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.